The table below shows Merck & Co., Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$16.29B
$17.28B
$15.81B
$15.53B
$16.66B
$16.11B
Cost of revenue
$4.20B
$3.85B
$3.56B
$3.42B
$4.08B
$3.75B
Gross profit
-
-
-
-
-
-
R&D
$12.59B
$4.23B
$4.05B
$3.62B
$5.86B
$3.50B
MRK annual revenue (10-K history)
Merck & Co., Inc. reported annual revenue of $65.01B for fiscal year 2025. That is up 1.3% from $64.17B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $39.81B (FY 2016) to $65.01B. Figures come from the company's audited annual reports as filed with the SEC.
